Panel to feature Aditee Kambli, Bharat Serums & Vaccines; Dr. Sushant Kumar, ImmunoACT; Satish Makkina, Procell Biologics; Dr ...
India has approved Qfitlia (Fitusiran), a new treatment designed to prevent or reduce bleeding episodes in people living with ...
Speakers include Parizad A. Elchidana, ACG World; Dr. Kiran Marthak, Veeda Life Sciences; Dr. Ravikrishna Chebolu, CSIR ...
With the approval, Cosentyx becomes the first and only interleukin-17A (IL-17A) inhibitor approved in Europe for adults with ...
The initiative will initially focus on patients with desmoid tumors and neurofibromatosis type 1 with plexiform neurofibromas ...
Based on I CAN Phase III trial results from prespecified interim analysis in which Ultomiris demonstrated 43.4% reduction in ...
The newly approved regimen offers a chemotherapy-free perioperative approach and is authorised for use across all 27 EU ...
Allergan Aesthetics is presenting new clinical findings at AMWC Dubai.
Launched in collaboration with Ameelio Healthcare Private Limited, the laboratory is aimed at expanding access to affordable, ...
Prolific has reported a productivity milestone of 21 grams per litre in a 15-day intensified fed-batch run for a monoclonal ...
Biotech firm Zealand Pharma has reported positive Phase 1 multiple ascending dose (MAD) results for ZP9830, its ...
Eli Lilly and Company has reported positive one-year results from a Phase 3 trial of Omvoh (mirikizumab-mrkz) in children and adolescents aged 6 to 17 with moderately to severely active ulcerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results